Roles of FGF signaling in stem cell self-renewal, senescence and aging

Aging

Volumn 3, Issue 10, 2011, Pages 920-933

  Coutu, Daniel L ^a   Galipeau, Jacques ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b EMORY UNIVERSITY   (United States)

Author keywords

Adult stem cells; Aging; Embryonic stem cells; Fibroblast growth factor; Self renewal; Senescence

Indexed keywords

EID: 80855165240     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100369     Document Type: Article

References (128)

1. Hayflick L, Moorhead PS.: The serial cultivation of human cell strains. Experimental Cell Research 1961, 621:585-621.
2. Hayflick L.: The limited in vitro lifetime of human diploid cell strains. Experimental Cell Research 1965, 37:614-636.
3. Rodier F, Campisi J.: Four faces of cellular senescence. The Journal of Cell Biology 2011, 192:547-556.
4. Wright WE, Shay JW.: Historical claims and current interpretations of replicative aging. Nature biotechnology 2002, 20:682-8.
5. Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, Sharpless NE.: Ink4a/Arf expression is a biomarker of aging. Journal of Clinical Investigation 2004, 114:1299-1307.
6. Itahana K, Campisi J, Dimri GP.: Mechanisms of cellular senescence in human and mouse cells. Biogerontology 2004, 5:1-10.
7. Vijg J, Campisi J.: Puzzles, promises and a cure for ageing. Nature 2008, 454:1065-71.
8. Powers CJ, McLeskey SW, Wellstein A.: Fibroblast growth factors, their receptors and signaling. Endocrine-related cancer 2000, 7:165-97.
9. Böttcher RT, Niehrs C.: Fibroblast growth factor signaling during early vertebrate development. Endocrine reviews 2005, 26:63-77.
10. Zhang X, Ibrahimi O a, Olsen SK, Umemori H, Mohammadi M, Ornitz DM.: Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. The Journal of biological chemistry 2006, 281:15694-700.
11. Rappolee D a, Basilico C, Patel Y, Werb Z.: Expression and function of FGF-4 in peri-implantation development in mouse embryos. Development 1994, 120:2259-69.
12. Feldman B, Poueymirou W, Papaioannou VE, DeChiara TM, Goldfarb M.: Requirement of FGF-4 for postimplantation mouse development. Science 1995, 267:246-9.
13. Chai N, Patel Y, Jacobson K, McMahon J, McMahon A, Rappolee DA.: FGF is an essential regulator of the fifth cell division in preimplantation mouse embryos. Developmental biology 1998, 198:105-15.
14. Arman E, Haffner-Krausz R, Chen Y, Heath JK, Lonai P.: Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:5082-7.
15. McDonald FJ, Heath JK.: Developmentally regulated expression of fibroblast growth factor receptor genes and splice variants by murine embryonic stem and embryonal carcinoma cells. Developmental genetics 1994, 15:148-54.
16. Deng CX, Wynshaw-Boris A, Shen MM, Daugherty C, Ornitz DM, Leder P.: Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes & Development 1994, 8:3045-3057.
17. Yamaguchi TP, Harpal K, Henkemeyer M, Rossant J.: Fgfr-1 Is Required for Embryonic Growth and Mesodermal Patterning During Mouse Gastrulation. Genes & Development 1994, 8:3032-3044.
18. Martin GR.: Isolation of a Pluripotent Cell Line from Early Mouse Embryos Cultured in Medium Conditioned by Teratocarcinoma Stem Cells. Proceedings of the National Academy of Sciences of the United States of America 1981, 78:7634-7638.
19. Evans M, Kaufman M.: Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-56.
20. Wilder PJ, Kelly D, Brigman K, Peterson CL, Nowling T, Gao QS, McComb RD, Capecchi MR, Rizzino a.: Inactivation of the FGF-4 gene in embryonic stem cells alters the growth and/or the survival of their early differentiated progeny. Developmental biology 1997, 192:614-29.
21. Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, Smith A.: FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 2007, 134:2895-902.
22. Lanner F, Rossant J.: The role of FGF/Erk signaling in pluripotent cells. Development 2010, 137:3351-60.
23. Dvorak P, Dvorakova D, Koskova S, Vodinska M, Najvirtova M, Krekac D, Hampl A.: Expression and potential role of fibroblast growth factor 2 and its receptors in human embryonic stem cells. Stem cells 2005, 23:1200-11.
24. Xu C, Rosler E, Jiang J, Lebkowski JS, Gold JD, O'Sullivan C, Delavan-Boorsma K, Mok M, Bronstein A, Carpenter MK.: Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem cells 2005, 23:315-23.
25. Vallier L, Alexander M, Pedersen R a.: Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. Journal of cell science 2005, 118:4495-509.
26. Levenstein ME, Ludwig TE, Xu R-H, Llanas R a, VanDenHeuvel-Kramer K, Manning D, Thomson J a.: Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem cells 2006, 24:568-74.
27. Thomson J a.: Embryonic Stem Cell Lines Derived from Human Blastocysts. Science 1998, 282:1145-1147.
28. Ding VMY, Ling L, Natarajan S, Yap MGS, Cool SM, Choo ABH.: FGF-2 modulates Wnt signaling in undifferentiated hESC and iPS cells through activated PI3-K/GSK3beta signaling. Journal of cellular physiology 2010, 225:417-28.
29. Yu P, Pan G, Yu J, Thomson J a.: FGF2 sustains NANOG and switches the outcome of BMP4-induced human embryonic stem cell differentiation. Cell stem cell 2011, 8:326-34.
30. Gospodarowicz D.: Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 1974, 249:123-7.
31. Gambarini a G, Armelin H a.: Purification and partial characterization of an acidic fibroblast growth factor from bovine pituitary. The Journal of biological chemistry 1982, 257:9692-7.
32. Maciag T, Mehlman T, Friesel R, Schreiber AB.: Heparin Binds Endothelial Cell Growth Factor, the Principal Endothelial Cell Mitogen in Bovine Brain. Science 1984, 225:932-935.
33. Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M.: Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor. Science 1984, 223:1296-1299.
34. Ornitz DM, Marie PJ.: FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes & development 2002, 16:1446-65.
35. Su N, Du X, Chen L.: FGF signaling: its role in bone development and human skeleton diseases. Frontiers in bioscience 2008, 13:2842-65.
36. Kronenberg HM.: Developmental regulation of the growth plate. Nature 2003, 423:332-6.
37. Ornitz DM.: FGF signaling in the developing endochondral skeleton. Cytokine & growth factor reviews 2005, 16:205-13.
38. Liu Z, Lavine KJ, Hung IH, Ornitz DM.: FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. Developmental biology 2007, 302:80-91.
39. Wang Q, Green RP, Zhao G, Ornitz DM.: Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains. Development 2001, 128:3867-76.
40. Valverde-Franco G, Liu H, Davidson D, Chai S, Valderrama-Carvajal H, Goltzman D, Ornitz DM, Henderson JE.: Defective bone mineralization and osteopenia in young adult FGFR3-/- mice. Human molecular genetics 2004, 13:271-84.
41. Verheyden JM, Lewandoski M, Deng C, Harfe BD, Sun X.: Conditional inactivation of Fgfr1 in mouse defines its role in limb bud establishment, outgrowth and digit patterning. Development 2005, 132:4235-45.
42. Jacob AL, Smith C, Partanen J, Ornitz DM.: Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Developmental biology 2006, 296:315-28.
43. Kaga Y, Shoemaker WJ, Furusho M, Bryant M, Rosenbluth J, Pfeiffer SE, Oh L, Rasband M, Lappe-Siefke C, Yu K, et al.: Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with Cnp1 inactivation. Journal of neuroscience: the official journal of the Society for Neuroscience 2006, 26:12339-50.
44. Eswarakumar VP, Monsonego-Ornan E, Pines M, Antonopoulou I, Morriss-Kay GM, Lonai P.: The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 2002, 129:3783-93.
45. Oliver LI, Rifkin DB, Gabrilove J, Hannocks M-J, Wilson EL.: Long-Term Culture of Human Bone Marrow Stromal Cells in the Presence of Basic Fibroblast Growth Factor. Growth Factors 1990, 3:231-236.
46. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R.: Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 1997, 138:4456-62.
47. Kuznetsov S a, Friedenstein a J, Robey PG.: Factors required for bone marrow stromal fibroblast colony formation in vitro. British journal of haematology 1997, 97:561-70.
48. Tsutsumi S, Shimazu a, Miyazaki K, Pan H, Koike C, Yoshida E, Takagishi K, Kato Y.: Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochemical and biophysical research communications 2001, 288:413-9.
49. Solchaga L a, Penick K, Goldberg VM, Caplan AI, Welter JF.: Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue engineering. Part A 2010, 16:1009-19.
50. Solchaga L a, Penick K, Porter JD, Goldberg VM, Caplan AI, Welter JF.: FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. Journal of cellular physiology 2005, 203:398-409.
51. Hanada K, Dennis JE, Caplan AI.: Stimulatory Effects of Basic Fibroblast Growth Factor and Bone Morphogenetic Protein-2 on Osteogenic Mesenchymal Stem Cells. Journal of Bone and Mineral Research 1997, 12:1606-1614.
52. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG.: Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. Journal of cellular biochemistry 2003, 89:1235-49.
53. Ng F, Boucher S, Koh S, Sastry KSR, Chase L, Lakshmipathy U, Choong C, Yang Z, Vemuri MC, Rao MS, et al.: PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and o. Blood 2008, 112:295-307.
54. Mansukhani A, Ambrosetti D, Holmes G, Cornivelli L, Basilico C.: Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. The Journal of cell biology 2005, 168:1065-76.
55. Basu-Roy U, Ambrosetti D, Favaro R, Nicolis SK, Mansukhani A, Basilico C.: The transcription factor Sox2 is required for osteoblast self-renewal. Cell death and differentiation 2010, 17:1345-53.
56. Quito FL, Beh J, Bashayan O, Basilico C, Basch RS.: Effects of fibroblast growth factor-4 (k-FGF) on long-term cultures of human bone marrow cells. Blood 1996, 87:1282-91.
57. Ito T, Sawada R, Fujiwara Y, Seyama Y, Tsuchiya T.: FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-beta2. Biochemical and biophysical research communications 2007, 359:108-14.
58. Coutu DL, François M, Galipeau J.: Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells. Blood 2011, 117:6801-12.
59. Bianchi G, Banfi A, Mastrogiacomo M, Natora R, Luzzatto L, Cancedda R, Quarto R.: Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Experimental Cell Research 2003, 287:98-105.
60. Meek DW, Knippschild U.: Posttranslational modification of MDM2. Molecular cancer research 2003, 1:1017-26.
61. Meek DW, Hupp TR.: The regulation of MDM2 by multisite phosphorylation--opportunities for molecular-based intervention to target tumours? Seminars in cancer biology 2010, 20:19-28.
62. Kassem M, Marie PJ.: Senescence-associated intrinsic mechanisms of osteoblast dysfunctions. Aging Cell 2011, 10:191-7.
63. van Hinsbergh VWM, Rabelink TJ.: FGFR1 and the bloodline of the vasculature. Arteriosclerosis, thrombosis, and vascular biology 2005, 25:883-6.
64. Mikkola HK a, Orkin SH.: The journey of developing hematopoietic stem cells. Development 2006, 133:3733-44.
65. Mustonen T, Alitalo K.: Endothelial receptor tyrosine kinases involved in angiogenesis. The Journal of cell biology 1995, 129:895-8.
66. Risau W.: Differentiation of endothelium. The FASEB journal 1995, 9:926.
67. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway a C, Rifkin DB, Mignatti P.: Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. The Journal of cell biology 1998, 141:1659-73.
68. Magnusson PU, Dimberg A, Mellberg S, Lukinius A, Claesson-welsh L.: FGFR-1 regulates angiogenesis through cytokines interleukin-4 and pleiotrophin. Angiogenesis 2007, 110:4214-4222.
69. Magnusson PU, Ronca R, Dell'Era P, Carlstedt P, Jakobsson L, Partanen J, Dimberg A, Claesson-Welsh L.: Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. Arteriosclerosis, thrombosis, and vascular biology 2005, 25:944-9.
70. Murakami M, Nguyen LT, Zhang ZW, Moodie KL, Carmeliet P, Stan RV, Simons M.: The FGF system has a key role in regulating vascular integrity. Journal of Clinical Investigation 2008, 118:3355-66.
71. Murakami M, Nguyen LT, Hatanaka K, Schachterle W, Chen P-yu, Zhuang ZW, Black BL, Simons M.: FGF-dependent regulation of VEGF receptor 2 expression in mice. Journal of Clinical Investigation 2011, 121:2668-78.
72. Murakami M, Simons M.: Fibroblast growth factor regulation of neovascularization. Current opinion in hematology 2008, 15:215-20.
73. Garfinkel S, Hu X, Prudovsky I a, McMahon G a, Kapnik EM, McDowell SD, Maciag T.: FGF-1-dependent proliferative and migratory responses are impaired in senescent human umbilical vein endothelial cells and correlate with the inability to signal tyrosine phosphorylation of fibroblast growth factor receptor-1 substrates. The Journal of cell biology 1996, 134:783-91.
74. Kurz DJ, Hong Y, Trivier E, Huang H-L, Decary S, Zang GH, Lüscher TF, Erusalimsky JD.: Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells. Arteriosclerosis, thrombosis, and vascular biology 2003, 23:748-54.
75. Trivier E, Kurz D, Hong Y.: Differential Regulation of Telomerase in Endothelial Cells by Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor-A: Association with Replicative Life. Annals of the New York Academy of Sciences 2004, 1019:111-15.
76. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M.: Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine & growth factor reviews 2005, 16:159-78.
77. Zhang C, Lodish HF.: Cytokines regulating hematopoietic stem cell function. Current opinion in hematology 2008, 15:307-311.
78. Gabbianelli M, Sargiacomo M, Pelosi E, Testa U, Isacchi G, Peschle C.: "Pure" Human Hematopoietic Progenitors: Permissive Action of Basic Fibroblast Growth Facto. Science 1990, 249:1561-4.
79. Brunner G, Nguyen H, Gabrilove J, Rifkin DB, Wilson EL.: Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 1993, 81:631-8.
80. Gabrilove JL, White K, Rahman Z, Wilson EL.: Stem cell factor and basic fibroblast growth factor are synergistic in augmenting committed myeloid progenitor cell growth. Blood 1994, 83:907-10.
81. Allouche M, Bikfalvi A.: The role of fibroblast growth factor-2 (FGF-2) in hematopoiesis. Progress in growth factor research 1995, 6:35-48.
82. Bikfalvi A, Han ZC, Fuhrmann G.: Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells. Blood 1992, 80:1905-13.
83. Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, Jin DK, Dias S, Zhang F, Hartman TE, et al.: Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nature Medicine 2004, 10:64-71.
84. Berardi a C, Wang a, Abraham J, Scadden DT.: Basic fibroblast growth factor mediates its effects on committed myeloid progenitors by direct action and has no effect on hematopoietic stem cells. Blood 1995, 86:2123-9.
85. Walenda T, Bokermann G, Ventura Ferreira MS, Piroth DM, Hieronymus T, Neuss S, Zenke M, Ho AD, Müller AM, Wagner W.: Synergistic effects of growth factors and mesenchymal stromal cells for expansion of hematopoietic stem and progenitor cells. Experimental hematology 2011, 39:617-28.
86. Zhang CC, Kaba M, Iizuka S, Huynh H, Lodish HF.: Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood 2008, 111:3415-23.
87. Drake AC, Khoury M, Leskov I, Iliopoulou BP, Fragoso M, Lodish H, Chen J.: Human CD34+ CD133+ hematopoietic stem cells cultured with growth factors including Angptl5 efficiently engraft adult NOD-SCID Il2rγ-/- (NSG) mice. PloS one 2011, 6:e18382.
88. Faloon P, Arentson E, Kazarov A, Deng CX, Porcher C, Orkin S, Choi K.: Basic fibroblast growth factor positively regulates hematopoietic development. Development 2000, 127:1931-41.
89. de Haan G, Weersing E, Dontje B, van Os R, Bystrykh LV, Vellenga E, Miller G.: In vitro generation of long-term repopulating hematopoietic stem cells by fibroblast growth factor-1. Developmental cell 2003, 4:241-51.
90. Shigematsu A, Shi M, Okigaki M, Adachi Y, Koike N, Che J, Iwasaki M, Matsubara H, Imamura M, Ikehara S.: Signaling from fibroblast growth factor receptor 2 in immature hematopoietic cells facilitates donor hematopoiesis after intra-bone marrow-bone marrow transplantation. Stem cells and development 2010, 19:1679-86.
91. Nakazawa F, Nagai H, Shin M, Sheng G.: Negative regulation of primitive hematopoiesis by the FGF signaling pathway. Blood 2006, 108:3335-43.
92. Schiedlmeier B, Santos AC, Ribeiro A, Moncaut N, Lesinski D, Auer H, Kornacker K, Ostertag W, Baum C, Mallo M, et al.: HOXB4 ' s road map to stem cell expansion. Proceedings of the National Academy of Sciences 2007, 104:16952-7.
93. Schroeder T.: Hematopoietic stem cell heterogeneity: subtypes, not unpredictable behavior. Cell stem cell 2010, 6:203-7.
94. Abbas H a, Maccio DR, Coskun S, Jackson JG, Hazen AL, Sills TM, You MJ, Hirschi KK, Lozano G.: Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity. Cell Stem Cell 2010, 7:606-17.
95. Liu Y, Elf SE, Asai T, Miyata Y, Liu Y, Sashida G, Huang G, Di Giandomenico S, Koff A, Nimer SD.: The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior. Cell cycle 2009, 8:3120-4.
96. Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, Cheng T, DePinho R a, Sharpless NE, Scadden DT.: Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 2006, 443:421-6.
97. Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissmann IL.: The aging hematopoietic stem cells. Nature Medicine 1996, 2:1011-6.
98. Miller FD, Gauthier-Fisher A.: Home at last: neural stem cell niches defined. Cell stem cell 2009, 4:507-10.
99. Weinandy F, Ninkovic J, Götz M.: Restrictions in time and space--new insights into generation of specific neuronal subtypes in the adult mammalian brain. The European journal of neuroscience 2011, 33:1045-54.
100. Costa MR, Götz M, Berninger B.: What determines neurogenic competence in glia? Brain research reviews 2010, 63:47-59.
101. Robel S, Berninger B, Götz M.: The stem cell potential of glia: lessons from reactive gliosis. Nature Reviews Neuroscience 2011, 12:88-104.
102. Storey KG, Goriely A, Sargent CM, Brown JM, Burns HD, Abud HM, Heath JK.: Early posterior neural tissue is induced by FGF in the chick embryo. Development 1998, 125:473-84.
103. Stern CD.: Neural induction: 10 years on since the "default model". Current opinion in cell biology 2006, 18:692-7.
104. Roisen F, Nickel DD, Vescovi AL.: Multipotential Stem Cells from the Adult Mouse and Self-Renew in Response to Basic Fibroblast. Journal of Neuroscience 1996, 16:1091-1100.
105. Reuss B, von Bohlen und Halbach O.: Fibroblast growth factors and their receptors in the central nervous system. Cell and tissue research 2003, 313:139-57.
106. Sirko S, von Holst A, Weber A, Wizenmann A, Theocharidis U, Götz M, Faissner A.: Chondroitin sulfates are required for fibroblast growth factor-2-dependent proliferation and maintenance in neural stem cells and for epidermal growth factor-dependent migration of their progeny. Stem cells 2010, 28:775-87.
107. Tropepe V, Sibilia M, Ciruna BG, Rossant J, Wagner EF, van der Kooy D.: Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Developmental biology 1999, 208:166-88.
108. Beer HD, Vindevoghel L, Gait MJ, Revest JM, Duan DR, Mason I, Dickson C, Werner S.: Fibroblast growth factor (FGF) receptor 1-IIIb is a naturally occurring functional receptor for FGFs that is preferentially expressed in the skin and the brain. The Journal of biological chemistry 2000, 275:16091-7.
109. Chadashvili T, Peterson DA.: Cytoarchitecture of Fibroblast Growth Factor Receptor 2 (FGFR-2) Immunoreactivity in Astrocytes of Neurogenic and Non-Neurogenic Regions of the Young Adult and Aged Rat Brain. Brain 2006, 15:1-15.
110. Ford-Perriss M, Abud H, Murphy M.: Brief review: fibroblast growth factors in the developing central nervous system. Clinical and Experimental Pharmacology and Physiology 2001, 28:493-503.
111. Temple S.: The development of neural stem cells. Nature 2001, 414:112-7.
112. Fortin D, Rom E, Sun H, Yayon A, Bansal R.: Distinct fibroblast growth factor (FGF)/FGF receptor signaling pairs initiate diverse cellular responses in the oligodendrocyte lineage. The Journal of neuroscience 2005, 25:7470-9.
113. Kerever A, Schnack J, Vellinga D, Ichikawa N, Moon C, Arikawa-Hirasawa E, Efird JT, Mercier F.: Novel extracellular matrix structures in the neural stem cell niche capture the neurogenic factor fibroblast growth factor 2 from the extracellular milieu. Stem cells 2007, 25:2146-57.
114. Topp S, Stigloher C, Komisarczuk AZ, Adolf B, Becker TS, Bally-Cuif L.: Fgf signaling in the zebrafish adult brain: association of Fgf activity with ventricular zones but not cell proliferation. Journal of comparative neurology 2008, 510:422-39.
115. Zhao C, Deng W, Gage FH.: Mechanisms and functional implications of adult neurogenesis. Cell 2008, 132:645-60.
116. Molofsky AV, Slutsky SG, Joseph NM, He S, Pardal R, Krishnamurthy J, Sharpless NE, Morrison SJ.: Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 2006, 443:448-52.
117. Brazel CY, Rao MS.: Stem cells and aging. Aging Health 2005, 1:49-58.
118. Jin K, Sun Y, Xie L, Batteur S, Mao XO, Smelick C, Logvinova A, Greenberg D a.: Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice. Aging Cell 2003, 2:175-83.
119. Yeoh JSG, de Haan G.: Fibroblast growth factors as regulators of stem cell self-renewal and aging. Mechanisms of ageing and development 2007, 128:17-24.
120. Oomura Y, Sasaki K, Li a, Yoshii H, Fukata Y, Yago H, Kimura H, Tooyama I, Hanai K, Nomura Y, et al.: Protection against impairment of memory and immunoreactivity in senescence-accelerated mice by acidic fibroblast growth factor. Annals of the New York Academy of Sciences 1996, 786:337-47.
121. Tooyama I, Sasaki K, Oomura Y, Li a J, Kimura H.: Effect of acidic fibroblast growth factor on basal forebrain cholinergic neurons in senescence-accelerated mice. Experimental gerontology 1997, 32:171-9.
122. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K.: Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. Journal of Clinical Investigation 2004, 113:561-568.
123. Cowan CM, Quarto N, Warren SM, Salim A, Longaker MT.: Age-related changes in the biomolecular mechanisms of calvarial osteoblast biology affect fibroblast growth factor-2 signaling and osteogenesis. The Journal of biological chemistry 2003, 278:32005-13.
124. Date I, Notter MF, Felten SY, Felten DL.: MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF). Brain research 1990, 526:156-60.
125. Ou G, Charles L, Matton S, Rodner C, Hurley M, Kuhn L, Gronowicz G.: Fibroblast growth factor-2 stimulates the proliferation of mesenchyme-derived progenitor cells from aging mouse and human bone. The journals of gerontology. Series A, Biological sciences and medical sciences 2010, 65:1051-9.
126. Komi-Kuramochi A, Kawano M, Oda Y, Asada M, Suzuki M, Oki J, Imamura T.: Expression of fibroblast growth factors and their receptors during full-thickness skin wound healing in young and aged mice. The Journal of endocrinology 2005, 186:273-89.
127. Shetty AK, Hattiangady B, Shetty G a.: Stem/progenitor cell proliferation factors FGF-2, IGF-1, and VEGF exhibit early decline during the course of aging in the hippocampus: role of astrocytes. Glia 2005, 51:173-86.
128. Beenken A, Mohammadi M.: The FGF family: biology, pathophysiology and therapy. Nature Reviews Drug discovery 2009, 8:235-53.